A ALIMENTARY TRACT AND METABOLISM

 B BLOOD AND BLOOD FORMING ORGANS

 C CARDIOVASCULAR SYSTEM

 D DERMATOLOGICALS

 G GENITO URINARY SYSTEM AND SEX HORMONES

 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS

 J ANTIINFECTIVES FOR SYSTEMIC USE

 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

   L01 ANTINEOPLASTIC AGENTS

     L01A ALKYLATING AGENTS

     L01B ANTIMETABOLITES

     L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS

     L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES

     L01X OTHER ANTINEOPLASTIC AGENTS

       L01XA Platinum compounds

       L01XB Methylhydrazines

       L01XC Monoclonal antibodies

       L01XD Sensitizers used in photodynamic/radiation therapy

       L01XE Protein kinase inhibitors

         L01XE01 Imatinib [DG:DG00710]

         L01XE02 Gefitinib

         L01XE03 Erlotinib [DG:DG00711]

         L01XE04 Sunitinib [DG:DG00712]

         L01XE05 Sorafenib [DG:DG00713]

         L01XE06 Dasatinib [DG:DG00714]

         L01XE07 Lapatinib [DG:DG00715]

         L01XE08 Nilotinib [DG:DG00716]

         L01XE09 Temsirolimus

         L01XE10 Everolimus

         L01XE11 Pazopanib

         L01XE12 Vandetanib

         L01XE13 Afatinib [DG:DG00717]

         L01XE14 Bosutinib [DG:DG00718]

         L01XE15 Vemurafenib

         L01XE16 Crizotinib

         L01XE17 Axitinib

         L01XE18 Ruxolitinib [DG:DG00719]

         L01XE19 Ridaforolimus

         L01XE21 Regorafenib [DG:DG00720]

         L01XE22 Masitinib

         L01XE23 Dabrafenib [DG:DG00721]

         L01XE24 Ponatinib [DG:DG00722]

         L01XE25 Trametinib [DG:DG00723]

         L01XE26 Cabozantinib [DG:DG01670]

         L01XE27 Ibrutinib

         L01XE28 Ceritinib

         L01XE29 Lenvatinib [DG:DG01362]

         L01XE31 Nintedanib [DG:DG01374]

         L01XE32 Cediranib [DG:DG01360]

         L01XE33 Palbociclib [DG:DG01831]

         L01XE34 Tivozanib [DG:DG01375]

         L01XE35 Osimertinib

         L01XE36 Alectinib [DG:DG01625]

         L01XE37 Rociletinib

         L01XE38 Cobimetinib [DG:DG01825]

         L01XE39 Midostaurin

         L01XE40 Olmutinib [DG:DG02916]

         L01XE41 Binimetinib

         L01XE42 Ribociclib [DG:DG02084]

         L01XE43 Brigatinib

         L01XE44 Lorlatinib

         L01XE45 Neratinib [DG:DG02303]

         L01XE46 Encorafenib

         L01XE47 Dacomitinib [DG:DG01793]

         L01XE48 Icotinib [DG:DG01793]

         L01XE50 Abemaciclib

         L01XE51 Acalabrutinib [DG:DG03089]

         L01XE52 Quizartinib [DG:DG01364]

         L01XE53 Larotrectinib [DG:DG02923]

         L01XE54 Gilteritinib [DG:DG01948]

         L01XE56 Entrectinib

         L01XE57 Fedratinib [DG:DG02968]

       L01XX Other antineoplastic agents

       L01XY Combinations of antineoplastic agents

   L02 ENDOCRINE THERAPY

   L03 IMMUNOSTIMULANTS

   L04 IMMUNOSUPPRESSANTS

 M MUSCULO-SKELETAL SYSTEM

 N NERVOUS SYSTEM

 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

 R RESPIRATORY SYSTEM

 S SENSORY ORGANS

 V VARIOUS